Recombinant Protein Calibrators and Controls for Quantitative Immunoassays

Recombinant protein calibrators and controls support quantitative immunoassays by providing defined analyte materials for calibration curves, assay-development experiments, quality-control samples and lot-to-lot performance monitoring. The most suitable protein should match the assay’s measurand, antibody epitopes, molecular format, concentration range and sample matrix as closely as practical. A catalog recombinant protein can provide an efficient starting point for research-use immunoassay development. Projects requiring a different sequence, tag, expression host, purity level, formulation, concentration or bulk quantity can also use semi-custom or fully custom protein production.

Beta LifeScience offers catalog recombinant cytokines, chemokines, growth factors, receptors and biomarker-related proteins for research-use immunoassay development. When an available product does not match the required sequence, expression host, tag, formulation, concentration or quantity, semi-custom and fully custom production options can be evaluated.

Recombinant Proteins to Evaluate for Quantitative Immunoassays

The following products represent relevant candidate analytes for research-use quantitative immunoassay development. They are not presented as universally certified, traceable or commutable calibrators. Review each current product page and complete assay-specific qualification before routine use.

Product suitability depends on the exact assay design. Confirm the sequence, expression system, tag, purity, formulation and current ordering options on the individual product page.

Choose a Catalog, Semi-Custom or Fully Custom Protein

Buyers can select a production route according to how closely an available recombinant protein matches the assay.

A catalog product can accelerate feasibility testing and early calibration-curve development. Semi-custom production may provide selected modifications to an established format, while fully custom expression offers broader control over protein sequence and production strategy.

Need a specific analyte, concentration or formulation?
Submit your quantitative immunoassay requirements for a catalog-product review or custom protein feasibility evaluation.

What Are Recombinant Protein Calibrators and Controls?

A calibrator is a material containing a known or assigned amount of analyte. Multiple calibrator concentrations are measured to establish the relationship between assay signal and analyte concentration. In an ELISA or another ligand-binding assay, signals from unknown samples are interpreted using this calibration curve.

A recombinant protein may be evaluated as a candidate calibrator when it provides:

• The required analyte identity
• Epitopes recognized by the assay antibodies
• A suitable molecular format
• Adequate purity
• Reliable concentration assignment
• Acceptable dilution behavior
• Stability under planned conditions
• Consistent performance across preparations

A control serves a different function. It monitors whether the assay performs within predefined expectations and is generally not used to construct the calibration curve.

Controls may include:

• Low QC near the lower working range
• Medium QC within the central range
• High QC near the upper range
• Blank control without target analyte
• Negative matrix control
• Interference or cross-reactivity controls

Calibration standards and QC samples may use the same recombinant protein during early research development. Independently prepared control stocks provide additional value because they can detect errors in calibration-stock preparation or dilution.

Calibrator, Control and Reference Material: Key Differences

The term “calibrator” describes how the material is being used within an assay. It does not automatically mean that the recombinant protein is a certified reference material, WHO International Standard or clinically commutable calibrator. For regulated or clinical measurement systems, additional requirements may apply to value assignment, traceability and commutability.

Match the Protein Format to the Measurand

The measurand is the specific quantity the immunoassay is intended to measure. Defining it clearly helps buyers select a suitable recombinant protein.

For example, a cytokine assay might be intended to measure:

• Mature free cytokine
• Total cytokine
• A specific isoform
• Endogenous cytokine in serum or plasma
• Recombinant cytokine in cell-culture medium
• Cytokine associated with another binding component

The candidate calibrator must contain the epitopes recognized by both capture and detection antibodies. Sequence boundaries, tags, mutations, folding and post-translational modifications may all affect antibody recognition.

Full-length proteins and fragments

A protein fragment can work effectively when it contains both antibody-binding sites and presents them in an accessible form. However, its size, folding and assay response may differ from those of the endogenous analyte. If antibody epitopes have not been mapped, comparing more than one protein construct can help identify the format that produces suitable binding and dilution behavior.

Tagged and tag-free proteins

Tags support purification and detection, but their position can influence antibody accessibility or apparent molecular mass. A tag-free protein may be useful when minimal structural additions are preferred. A tagged protein can still provide suitable performance when its tag is distant from the antibody-binding sites and does not influence calibration-curve behavior.

Expression system and molecular structure

The expression host can influence folding, glycosylation, disulfide bonding, processing and oligomeric state. An E. coli-expressed protein may suit an assay when the antibodies recognize accessible peptide epitopes and mammalian glycosylation is not required. Mammalian expression may be more appropriate when recognition depends on complex folding or glycan-associated structure. Some cytokines and growth factors naturally form dimers or other assemblies. Their oligomeric state can influence epitope accessibility and assay signal. SEC-HPLC or another suitable analytical method may be valuable when monomer, oligomer or aggregate content affects performance.

Compare Recombinant and Endogenous Analyte Behavior

A recombinant protein can generate a consistent calibration curve while showing a different response from the endogenous analyte in serum, plasma, cell-culture supernatant or another biological matrix.

Differences may result from:

• Glycosylation
• Natural processing
• Isoform distribution
• Binding partners
• Aggregation or degradation
• Matrix interactions
• Epitope accessibility

Serially diluted biological samples can be compared with recombinant calibrator dilutions. Similar dilution behavior provides useful evidence that the materials respond proportionally within the tested assay. A difference in slope can guide further optimization of the protein format, sample dilution, antibody pair or matrix composition. This is why a catalog protein should be treated as a candidate material until it has been qualified in the intended assay.

Build an Appropriate Calibration Curve

A calibration curve should cover the concentrations expected in study samples and contain enough levels to characterize the assay response.

A typical research-use design may include:

1. A blank
2. A lower-limit standard
3. Several intermediate standards
4. A standard near the upper working range
5. Independently prepared low, medium and high QC samples

Curve development should evaluate:

• Lower and upper limits of quantification
• Accuracy of back-calculated standards
• Precision between replicates
• Signal separation from the blank
• Regression model and weighting
• Hook effect at elevated concentrations
• Performance across multiple assay runs

The final number of calibrators, replicate strategy and acceptance criteria should reflect the assay’s intended use and validation plan.

Prepare Standards in a Relevant Matrix

Calibration diluent can influence protein recovery and antibody binding. Buffer-only standards may behave differently from biological samples containing abundant proteins, lipids, salts and analyte-binding components.

Possible calibration matrices include:

• Assay buffer
• Protein-containing diluent
• Analyte-depleted serum or plasma
• Surrogate matrix
• Cell-culture medium
• Tissue-extract diluent
• Matched biological matrix

The selected matrix should support consistent recovery while representing the intended samples as closely as practical. When an analyte-free biological matrix is unavailable, a surrogate matrix can be evaluated through spike recovery, dilutional parallelism and comparison with representative study samples.

Evaluate Spike Recovery and Parallelism

Spike-and-recovery testing

Spike recovery measures how much recombinant analyte can be detected after addition to the intended sample matrix.

It can identify influences from:

• Matrix interference
• Analyte-binding proteins
• Protein adsorption
• Proteolysis
• Antibody competition
• Dilution composition

More than one sample and spike concentration can be included because matrix effects may vary among specimens.

Dilutional parallelism

Parallelism compares serial dilutions of positive biological samples with the calibration curve. Similar behavior supports proportional recognition of the endogenous and recombinant analytes under the tested conditions. Spike recovery and parallelism provide complementary information. Suitable recovery of an added recombinant protein does not independently establish that endogenous analyte behaves identically.

Verify Concentration, Identity and Purity

Quantitative results depend directly on the assigned concentration of the calibrator stock.

Potential analytical methods include:

• Amino-acid analysis
• UV absorbance using an appropriate extinction coefficient
• Total-protein assay
• Intact-mass analysis
• Peptide mapping
• SDS-PAGE
• SEC-HPLC
• Lot-specific Certificate of Analysis

Different concentration methods can produce different results, particularly when the product contains a tag, carrier protein, stabilizer or heterogeneous glycosylation. Document the selected method, calculation assumptions, reconstitution volume and dilution procedure. Independently prepared QC stocks provide a stronger check on calibration-stock preparation.

Test Stability and Handling Conditions

Recombinant calibrators and controls should remain sufficiently stable throughout preparation, storage and measurement.

A fit-for-purpose stability plan may assess:

• Short-term benchtop stability
• Refrigerated stability
• Frozen storage
• Freeze–thaw cycles
• Prepared-plate stability
• Diluted working-standard stability
• Long-term storage
• Compatibility with low-binding tubes

Low-concentration proteins can adsorb to plastic surfaces. An appropriate carrier protein, surfactant or validated matrix may improve recovery, provided it remains compatible with the antibodies and detection chemistry. Prepare single-use aliquots when repeated freeze–thaw exposure affects performance. Record the protein lot, concentration, reconstitution date, aliquot volume and storage conditions.

Need recombinant protein with project-specific QC?
Submit the target, assay format, required protein configuration, quantity, concentration, formulation and analytical expectations for a technical feasibility review.

Design Controls Across the Working Range

Quantitative immunoassay controls should challenge the complete calibration range.

Low control

A low QC monitors performance near the lower limit of quantification, where small signal changes can have a larger proportional effect.

Medium control

A medium QC evaluates routine consistency within the central portion of the curve.

High control

A high QC monitors performance near the upper working range and may identify changes in curve shape, signal saturation or sample-dilution behavior. Controls can be tested across multiple plates, days, analysts and instruments according to the assay’s intended use. Defined acceptance ranges then support run-level decisions and performance trending.

Plan for Lot-to-Lot Continuity

New protein lots can differ in concentration assignment, purity, aggregation, modification profile or immunoreactivity. A lot-bridging study can compare:

• Old and new protein lots
• Complete calibration curves
• Low, medium and high controls
• Representative biological samples
• Spike recovery
• Dilutional parallelism
• Short-term precision

Purchasing enough material from one lot can simplify longer studies. Bulk quantity or dedicated-lot production can be discussed when an assay program requires repeat supply and consistent preparation.

How Beta LifeScience Supports Immunoassay Development

A buyer can begin with an available recombinant protein for preliminary feasibility testing and calibration-curve development. The initial evaluation can determine whether the protein’s sequence, host, tag and formulation match the assay. When selected changes are required, researchers can request review of a modified concentration, buffer, tag, endotoxin level or package configuration through semi-custom production. A project requiring a new isoform, mutation, sequence range, tag-free format or expression host can move to fully custom protein expression. The requested analytical package can be reviewed and confirmed during technical evaluation.

Longer assay-development programs can also include bulk quantity or dedicated-lot requirements in the initial request. This supports earlier planning for feasibility studies, validation experiments, control preparation and repeat testing.

A useful project brief should include:

• Target protein and species
• Accession number or sequence
• Required isoform or amino-acid range
• Intended immunoassay and sample matrix
• Capture and detection antibody information
• Desired expression system
• Tag or tag-free requirement
• Required quantity and concentration
• Buffer and formulation preference
• Purity, monomer or endotoxin expectations
• Requested analytical methods
• Study duration and lot-continuity needs

Frequently Asked Questions

Can any recombinant protein be used as an ELISA standard?

A recombinant protein can be evaluated as an ELISA standard when it contains the required antibody epitopes and performs consistently across the intended range. Concentration, molecular format, matrix behavior and stability should be qualified before routine use.

What is the difference between a calibrator and a control?

A calibrator establishes the relationship between assay signal and analyte concentration. A control monitors whether the assay performs within an expected range and is generally not used to build the calibration curve.

Should calibrators and controls use separate stock solutions?

Independent preparation is valuable because it allows controls to detect errors in the calibration stock or dilution series. The final strategy should match the assay’s development and validation plan.

Does a research-grade protein provide metrological traceability?

Not automatically. Traceability requires a documented calibration hierarchy and suitable value assignment. Certified or international reference materials should be incorporated when the intended measurement system requires them.

Can a custom protein be produced for an immunoassay?

Custom production can be evaluated when an assay requires a specific sequence, species, expression system, tag, formulation, concentration, quantity or analytical package. Feasibility and final deliverables are confirmed during technical evaluation.

Conclusion:

Recombinant proteins can provide practical candidate materials for quantitative immunoassay calibration and control preparation. Selection should consider the measurand, antibody recognition, molecular format, expression host, assigned concentration, matrix behavior, stability and intended use. Start with a catalog protein when its format fits the assay, or request semi-custom, fully custom or bulk production when additional control is required.

Ready to select a recombinant calibrator or control?
Browse recombinant proteins or submit a project evaluation with the analyte, assay range, matrix, required format, quantity and analytical expectations.

Selected References

1. U.S. Food and Drug Administration. Bioanalytical Method Validation Guidance for Industry.
2. U.S. Food and Drug Administration. M10 Bioanalytical Method Validation and Study Sample Analysis.
3. National Institute of Standards and Technology. Recommendations for Assessing Commutability of Reference Materials.
4. National Institute for Biological Standards and Control. WHO International Standards Catalogue.